Oric Pharmaceuticals, Inc. (ORIC) vs Tyra Biosciences, Inc. (TYRA)

Oric Pharmaceuticals, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Oric Pharmaceuticals, Inc. and Tyra Biosciences, Inc. are of similar size ($1.3B and $1.3B). Across the 9 metrics below, Oric Pharmaceuticals, Inc. leads on 5 and Tyra Biosciences, Inc. on 4.

Valuation

Metric ORIC TYRA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 3.50 3.46 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (10.93%) (12.96%) (33.15%)
Free cash flow yield (8.42%) (8.99%) (25.50%)

Profitability

Metric ORIC TYRA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.80%) (45.31%) (56.36%)
Return on assets (37.35%) (42.15%) (48.04%)
Return on invested capital (83.77%) 0.00% 0.00%

Growth

Metric ORIC TYRA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 19.67% (33.11%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORIC TYRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.19 14.91 4.72
Net debt to EBITDA 1.95 1.94 0.96

Dividend

Metric ORIC TYRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ORIC TYRA Biotechnology median
Market cap 1.32b 1.31b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack